The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial
European Journal of Cancer2019Vol. 109, pp. 51–60
Citations Over TimeTop 1% of 2019 papers
Sandro Pasquali, Sara Pizzamiglio, Nathan Touati, Saskia Litière, Sandrine Marréaud, Bernd Kasper, Hans Gelderblom, Silvia Stacchiotti, Ian Judson, Angelo Paolo Dei Tos, Paolo Verderio, Paolo G. Casali, Penella J. Woll, Alessandro Gronchi
Related Papers
- → Nominal nomograms and marginal margins: what is the law of the line?(2016)24 cited
- → Development of a Nomogram to Predict the Outcome for Patients with Soft Tissue Sarcoma(2023)3 cited
- → 67P Sintilimab, doxorubicin and ifosfamide (AI) as first-line treatment in patients with advanced soft tissue sarcoma: A single-arm phase II trial(2021)2 cited
- → Single-Agent Doxorubicin versus Doxorubicin Plus Ifosfamide in Advanced Soft Tissue Sarcoma(2012)
- [Continuous-infusion high dose ifosfamide as salvage treatment for pre-treated soft tissue sarcoma].(2002)